Michael A. Metzger
2019
In 2019, Michael A. Metzger earned a total compensation of $2.7M as Chief Operating Officer at Syndax Pharmaceuticals, a 77% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $252,000 |
|---|---|
| Option Awards | $1,901,541 |
| Salary | $540,346 |
| Other | $3,000 |
| Total | $2,696,887 |
Metzger received $1.9M in option awards, accounting for 71% of the total pay in 2019.
Metzger also received $252K in non-equity incentive plan, $540.3K in salary and $3K in other compensation.
Rankings
In 2019, Michael A. Metzger's compensation ranked 4,525th out of 13,971 executives tracked by ExecPay. In other words, Metzger earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,525 out of 13,971 | 68th |
Division Manufacturing | 1,686 out of 5,695 | 70th |
Major group Chemicals And Allied Products | 587 out of 2,194 | 73rd |
Industry group Drugs | 494 out of 1,880 | 74th |
Industry Pharmaceutical Preparations | 374 out of 1,392 | 73rd |
Source: SEC filing on April 29, 2020.
Metzger's colleagues
We found two more compensation records of executives who worked with Michael A. Metzger at Syndax Pharmaceuticals in 2019.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019